ClinicalTrials.Veeva

Menu

Effect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin Therapy (LGIM)

U

Universidad de Valparaiso

Status

Completed

Conditions

Diabetes Mellitus, Type 2

Treatments

Other: Low-glycemic index
Other: Control

Study type

Interventional

Funder types

Other

Identifiers

NCT03165877
035-2013

Details and patient eligibility

About

To compare the effect of low-glycemic index versus control lunches and dinners intake on indicators of satiety, metabolic parameters and liver steatosis degree on women with type 2 diabetes under metformin therapy.

Enrollment

13 patients

Sex

Female

Ages

30 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjets with type 2 diabetes mellitus diagnosis under metformin therapy.
  • Female sex.
  • Aged 30 to 65 years.
  • Body Mass Index (BMI) 22 to 34.9 kg / m2.

Exclusion criteria

  • Women with insulin-releasing drugs or insulin treatment.
  • Patients with diabetic nephropathy, retinopathy, chronic kidney disease, stroke.
  • Subjects with hypothyroidism without treatment.
  • Individuals with food allergies or intolerances.
  • Women who present an intake of ≥20 g of alcohol per day quantified through a closed consumption frequency survey.
  • Patients with previously diagnosed hepatitis, hepatic cirrhosis or liver cancer.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

13 participants in 2 patient groups

Low-glycemic index
Experimental group
Description:
Low-glycemic index lunches and dinners (\<55%)
Treatment:
Other: Low-glycemic index
Control
Active Comparator group
Description:
Medium/high glycemic index lunches and dinners (\>60%)
Treatment:
Other: Control

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems